Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

ASX 200 opens 0.1% higher; Westpac, Cochlear, Ampol report earnings

EditorOliver Gray
Published 19/02/2024, 08:34 am
© Reuters

Investing.com - The Australian stock market opened slightly higher on Monday, with about 80 leading listed companies set to announce their earnings over the next five days.

The ASX 200 futures are up by 0.1% to 7607, indicating a promising start to the week for the Australian market, despite a lackluster performance from Wall Street.

Trading may start off at a slower pace this week, given the closure of the U.S. market in observance of Presidents’ Day.

On Friday, the S&P 500 receded from its peak, closing down by 0.5% after a U.S. inflation report, specifically the producer price index, revealed an increase in prices due to a substantial rise in service costs.

For the ASX 200, last week ended on a positive note, with a 0.2% increase over five days of trading, closing at 7658.32. This places it just 0.5% shy of its record high, attained on February 2.

Upgrade your trading decisions with InvestingPro - Receive an additional 10% off the Pro+ subscription using the promo code "INVPRODEAL".

The current earnings season in both Australia and the U.S. has surprised many market observers with its strength, providing a boost to equity markets. Out of approximately a third of ASX's major companies that have reported their results for the December half, 47% have exceeded market expectations, whereas 34% have fallen short.

Among the companies to watch this week, Westpac Banking Corp (ASX:WBC) has reported a cash profit of $1.5 billion for the first quarter of its calendar year. This figure is 6% lower than the average of its two previous halves, as the competition for loans and deposits has reduced the net interest margin to 1.78%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the meantime, A2 Milk Company Ltd (ASX:A2M) has reported a marginal increase in its revenue and profit for the first half of FY24, attributing this growth to the performance of its products in the Chinese market.

Cochlear Ltd (ASX:COH), a medical technology company, has also seen a substantial increase in its sales revenue, which rose by 25% to $1.1 billion. Additionally, its statutory net profit surged by 35% to $191 million.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.